STOCK TITAN

Tandem Diabetes Care (TNDM) legal chief reports RSU vesting, tax withholding and ESPP purchase

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tandem Diabetes Care EVP & Chief Legal Officer Shannon M. Hansen reported routine equity compensation activity in company stock. On May 15, 2026, she exercised restricted stock units covering a total of 10,201 shares of common stock, and 5,192 shares were withheld by the company to satisfy tax obligations; footnotes state no shares were sold on the market. She also voluntarily reported acquiring 1,886 shares through the company’s Employee Stock Purchase Plan at $10.90 per share. Following these transactions, she directly holds 28,285 shares of common stock and indirectly holds 1,935 shares through the Shannon M. Hansen Trust.

Positive

  • None.

Negative

  • None.
Insider Hansen Shannon Marie
Role EVP & Chief Legal Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 1,437 $0.00 --
Exercise Restricted Stock Unit 1,097 $0.00 --
Exercise Restricted Stock Unit 7,667 $0.00 --
Exercise Common Stock 1,437 $0.00 --
Tax Withholding Common Stock 732 $12.82 $9K
Exercise Common Stock 1,097 $0.00 --
Tax Withholding Common Stock 559 $12.82 $7K
Exercise Common Stock 7,667 $0.00 --
Tax Withholding Common Stock 3,901 $12.82 $50K
Grant/Award Common Stock 1,886 $10.90 $21K
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct, null); Common Stock — 24,713 shares (Direct, null); Common Stock — 1,935 shares (Indirect, Shannon M. Hansen Trust)
Footnotes (1)
  1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c). The securities are held by the Shannon M. Hansen Trust dated July 8, 2003, of which Shannon M. Hansen is the Trustee. Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Awarded on May 23, 2024 pursuant to the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Awarded on May 30, 2025 pursuant to the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
RSU shares exercised 10,201 shares Restricted stock units converted to common stock on May 15, 2026
Shares withheld for taxes 5,192 shares Withheld by Tandem Diabetes Care to satisfy tax obligations on RSU vesting
ESPP purchase 1,886 shares at $10.90/share Acquired under Employee Stock Purchase Plan for period ending May 15, 2026
Direct common stock holdings 28,285 shares Total common shares directly owned after transactions
Indirect trust holdings 1,935 shares Common shares held by Shannon M. Hansen Trust after transactions
RSU balance (award example) 15,335 RSUs Restricted stock units remaining after one of the vesting events
Restricted Stock Unit financial
"Each RSU represents a contingent right to receive either one share of common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Purchase Plan financial
"acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(c) regulatory
"This transaction is also exempt under Rule 16b-3(c)."
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
Long-Term Incentive Plan financial
"Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan"
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
tax withholding requirements financial
"Shares withheld by Tandem Diabetes Care Inc. to satisfy tax withholding requirements on vesting of restricted stock units"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hansen Shannon Marie

(Last)(First)(Middle)
12400 HIGH BLUFF DRIVE

(Street)
SAN DIEGO CALIFORNIA 92130

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TANDEM DIABETES CARE INC [ TNDM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M1,437A$024,713D
Common Stock05/15/2026F(1)732D$12.8223,981D
Common Stock05/15/2026M1,097A$025,078D
Common Stock05/15/2026F(1)559D$12.8224,519D
Common Stock05/15/2026M7,667A$032,186D
Common Stock05/15/2026F(1)3,901D$12.8228,285D
Common Stock05/15/2026A(2)1,886A$10.930,171D
Common Stock1,935IShannon M. Hansen Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(4)(5)05/15/2026M1,437 (6) (6)Common Stock1,437$00D
Restricted Stock Unit(7)(5)05/15/2026M1,097 (8) (8)Common Stock1,097$04,387D
Restricted Stock Unit(9)(5)05/15/2026M7,667 (10) (10)Common Stock7,667$015,335D
Explanation of Responses:
1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
2. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c).
3. The securities are held by the Shannon M. Hansen Trust dated July 8, 2003, of which Shannon M. Hansen is the Trustee.
4. Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
5. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
6. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
7. Awarded on May 23, 2024 pursuant to the 2023 Plan.
8. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
9. Awarded on May 30, 2025 pursuant to the 2023 Plan.
10. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Remarks:
/s/ Shannon M. Hansen05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did TNDM executive Shannon Hansen report?

Shannon Hansen reported equity compensation activity including RSU vesting, tax withholding, and an ESPP purchase. She exercised restricted stock units into common shares and had some shares withheld for taxes, while also buying stock through Tandem Diabetes Care’s employee stock purchase plan.

Did the TNDM insider sell any shares in the open market?

No open-market sales were reported. Footnotes state the company withheld shares solely to satisfy tax withholding requirements on RSU vesting, and explicitly note that no shares were sold, indicating these dispositions were for taxes, not discretionary market sales.

How many Tandem Diabetes Care shares did Shannon Hansen acquire through RSUs?

She exercised restricted stock units covering a total of 10,201 shares of Tandem Diabetes Care common stock. These RSUs converted into shares as part of her long-term incentive awards, with a portion of the resulting shares then withheld to cover tax obligations due at vesting.

What was the size and price of Shannon Hansen’s ESPP purchase in TNDM stock?

She acquired 1,886 shares of common stock through the Employee Stock Purchase Plan at $10.90 per share. The footnote describes this as a voluntary report for the ESPP purchase period running from November 18, 2025 through May 15, 2026, exempt under Rule 16b-3(c).

What are Shannon Hansen’s TNDM share holdings after these transactions?

After the reported transactions, she directly holds 28,285 shares of Tandem Diabetes Care common stock and indirectly holds 1,935 shares through the Shannon M. Hansen Trust. These figures reflect her updated ownership position following RSU vesting, tax withholding, and ESPP participation.

How were restricted stock units structured in TNDM’s 2023 Long-Term Incentive Plan?

Footnotes explain RSU awards under the 2023 Long-Term Incentive Plan generally vest 33% on a specified May 15 date, with remaining shares vesting in eight equal quarterly installments. Each RSU represents a contingent right to one share of common stock or cash, at the issuer’s discretion.